1. Introduction {#s0005}
===============

Our research group has focused on discovering novel compounds from microbial metabolites[@bib1], [@bib2], [@bib3], [@bib4]. Compounds were screened from our original culture collection using LC--UV and LC--MS/MS instruments. During this chemical screening program, the actinomycete strain *Kitasatospora* sp. P07101 was found to produce unidentified compounds. Novel hazimycins, hazimycins B (**1**), C (**2**), and D (**3**), were recently isolated from the fermentation broth along with the known antibiotic hazimycin[@bib5] (renamed hazimycin A (**4**), [Fig. 1](#f0005){ref-type="fig"}). These new congeners possessed a diaryl skeleton that contained isonitrile and nitrile groups, which are rare among microbial metabolites. The isolation, structure elucidation, and biological activities of **1**--**3** have been described in the present study.

2. Results and discussion {#s0010}
=========================

2.1. Structure elucidation of **1**--**3** {#s0015}
------------------------------------------

The physicochemical properties of compounds **1**--**3** are summarized in [Table 1](#t0010){ref-type="table"}. Compounds **1**--**3** showed UV absorption between approximately 212 nm and 289 nm, which was identical to that of **4**. The IR absorption at 2150--2300 cm^--1^ suggested the presence of isonitrile and/or nitrile groups in their structures. These results indicated that the basic skeleton of **1**--**3** was similar to that of **4**.

The structure of **1** was elucidated from various spectral data including NMR experiments. The molecular formula of **1** was determined to be C~20~H~20~N~4~O~5~ based on HR-ESI-MS measurements, which indicated that the molecular formula of **1** has one oxygen atom and two hydrogen atoms more than that of **4**. The ^13^C-NMR spectrum showed 20 resolved signals, which were classified into two *sp*^3^ methylene carbons, two *sp*^3^ methine carbons, six *sp*^2^ methine carbons, four *sp*^2^ quaternary carbons, two *sp*^2^ quaternary oxycarbons, one *sp* carbon, two *sp*^2^ carbonyl carbons, and one *sp*^2^ formyl carbon by ^1^H--^13^C heteronuclear single-quantum correlation (HSQC) analysis. The ^1^H NMR spectrum (in DMSO-*d*~6~) displayed 18 proton signals. The connectivity of the proton and carbon atoms was established from the ^1^H--^13^C HSQC spectrum ([Table 2](#t0005){ref-type="table"}). A comparison of the NMR spectra of **1** and **4** indicated that they both possessed a dihydroxydiaryl skeleton. However, most double signals were observed in the ^1^H and ^13^C NMR spectra of **1**, suggesting that **1** was a heterodimer, while **4** was a homodimer. A formyl proton signal (*δ* 7.92) and amide proton signal (*δ* 8.17) were observed in **1**, but were absent in **4**, which indicated that one of two isonitrile groups was converted to an NH-formyl group in **1**. Cross peaks were observed from H-2″ (*δ* 4.43) to C-4″ (*δ* 160.9) as well as from NH-2″ (*δ* 8.17) to C-4″ in the ^13^C--^1^H heteronuclear multiple-bond correlation (HMBC) experiments ([Fig. 2](#f0010){ref-type="fig"}A). The structure satisfied the unsaturation number, UV spectra, and molecular formula. These results indicated that compound **1** was a 2″-NH-formyl hazimycin, as shown in [Fig. 1](#f0005){ref-type="fig"}.

The molecular formula of **2** was identical to that of **1**. However, two proton signals of an NH-formyl group (*δ* 8.06 and 8.86) were newly observed, and one of the amide proton signals of the two carboxamide groups (*δ* 7.48 and 7.71) disappeared in the ^1^H NMR spectrum of **2**. Furthermore, a new *sp* carbon signal (*δ* 119.0) was observed in place of one of the two carboxamide carbon signals (*δ* 167.1) in the ^13^C NMR spectrum of **2**. These results indicated the formylation of another isonitrile group of **1** and the conversion of one of the two carboxamide groups of **1** to a nitrile group in **2**. The position of the nitrile group was confirmed by ^13^C--^1^H HMBC experiments ([Fig. 2](#f0010){ref-type="fig"}B): cross peaks were observed from H-2 (*δ* 4.98) to C-1 (*δ* 119.0) and C-4 (*δ* 161.1). Thus, compound **2** was elucidated to be 2,2″-NH-formyl and 2-nitrle hazimycin ([Fig. 1](#f0005){ref-type="fig"}).

As listed in [Table 1](#t0010){ref-type="table"}, the molecular formula of **3** has one oxygen atom and two hydrogen atoms fewer than that of **2**. Its ^1^H-NMR spectrum revealed homodimer-type proton signals, and was almost identical to that of **2** except for the disappearance of the amide proton signals of the carboxamide groups (*δ* 7.04 and 7.48) in **3**. Furthermore, the presence of a nitrile carbon signal (*δ* 119.0) was confirmed as well as **2** in the ^13^C-NMR spectrum, which indicated that another carboxamide group of **2** was converted to a nitrile group in **3**. Finally, cross peaks were observed from H-2″ (*δ* 4.90) to C1″ (*δ* 119.0) and C4″ (*δ* 161.1) as well as from NH-2″ (*δ* 8.86) to C4″ in the ^13^C--^1^H HMBC experiments. Thus, compound **3** was elucidated to be a 2,2″-NH-formyl and 2,2″-nitrile hazimycin ([Fig. 1](#f0005){ref-type="fig"})

Regarding the absolute stereochemistry of the novel hazimycin analogs, dityrosine was prepared by hydrolyzing **4** under acidic conditions because its optical rotation has already been accurately described in previous studies[@bib6]. The results obtained in this study were consistent with those of [l]{.smallcaps},[l]{.smallcaps}-dityrosine. Thus, the absolute stereochemistry of 2 and 2″ of **4** was defined as *S*. Similarly, the hazimycin congeners **1**--**3** are considered to be derived from [l]{.smallcaps},[l]{.smallcaps}-dityrosine because they are generated *via* common biosynthetic pathway. Thus, compounds **1**--**3** should have the same absolute stereochemistry as **4**.

Waitz et al.[@bib7] previously reported that hazimycin A was biosynthesized from tyrosine and methionine based on ^14^C-labeling experiments. They postulated that an isonitrile group was formed through the NH-formyl residue generated due to the methylation, reduction, and oxidation of an amino group of tyrosine. In the present study, we demonstrated the presence and structure of not only the NH-formyl product, but also the new family of nitrile-type hazimycins in the culture broth of the actinomycete strain.

2.2. Antimicrobial activities of **1**--**3** {#s0020}
---------------------------------------------

We examined antimicrobial activity against 7 test microorganisms using the paper disk method[@bib8]. As shown in [Table 3](#t0015){ref-type="table"}, compounds **1**--**3** and dityrosine did not inhibit the growth of these microorganisms; only compound **4** exhibited antimicrobial activity against *Mycobacterium smegmatis*, *Bacillus subtilis*, *Staphylococcus aureus*, *Micrococcus luteus*, and *Candida albicans* with inhibition zones of 19, 14, 23, 26 and 20 mm, respectively. These results indicated that the attachment of both isonitrile groups in the side chain of the dihydroxydiaryl skeleton was crucial for antimicrobial activity.

3. Material and methods {#s0025}
=======================

3.1. General procedures {#s0030}
-----------------------

The actinomycete strain *Kitasatospora* sp. P07101 was originally isolated from a soil sample collected at Minato-ku, Tokyo, Japan. The genus was determined based on taxonomic studies and genetic analysis of 16S rRNA by the identification services of TechnoSuruga Laboratory Co., Ltd., Shizuoka, Japan. This strain was used to produce **1**--**3**. UV spectra were recorded on a spectrophotometer (8453 model, Agilent). IR spectra were recorded on a Fourier transform infrared spectrometer (FT-710, Horiba). Optical rotations were measured with a digital polarimeter (DIP-370, JASCO). FAB-MS spectra and HR-FAB-MS spectra were recorded on a mass spectrometer (JMS-AX505HA, JEOL). The various NMR spectra were collected with a spectrometer (XL-400, Varian).

3.2. Isolation of **1**--**3** {#s0035}
------------------------------

The three-day-old fermentation broth (6.5 L) of *Kitasatospora* sp. P07101 was centrifuged to separate the mycelia and supernatant. A part of the supernatant (4.0 L) was then added to a Diaion HP-20 column (volume: 0.2 L, Mitsubishi Chemical Co.) After washing with distilled water (1.0 L), the desired substances were eluted with MeOH (1.0 L) and concentrated *in vacuo* to dryness to produce red brown materials (2.3 g), which were then dissolved in MeOH and purified using high performance liquid chromatography (HPLC, column: DevelosilC30, 250 mm × 20 mm, Nomura Scientific Co.; solvent: a gradient system of 40 min from 5% CH~3~CN containing 0.05% trifluoroacetic acid (TFA) to 55% CH~3~CN containing 0.05% TFA; detection: UV at 210 nm; flow: 8.0 mL/min). Under these conditions, the peaks eluted at retention time of 18.8 and 27.8 min were repeatedly collected and concentrated to dryness to give **1** (1.0 mg) and **4** (110 mg) as pale yellow powders, respectively.

A residual supernatant (2.5 L) was extracted twice with an equal volume of ethylacetate, and concentrated *in vacuo* to dryness to produce red brown materials (1.2 g). This sample was dissolved in MeOH, and then purified using HPLC (column: PEGASIL ODS, 250 mm×20 mm, Senshu Scientific Co.; solvent: a gradient system of 60 min from 10% CH~3~CN containing 0.05% TFA to 45% CH~3~CN containing 0.05% TFA; detection: UV at 210 nm; flow: 6.0 mL/min). Under these conditions, the peaks eluted at retention time of 27 and 40 min were repeatedly collected and concentrated to dryness to give **2** (44.4 mg) and **3** (55.2 mg) as colorless oils, respectively.

3.3. Preparation of dityrosine {#s0040}
------------------------------

Dityrosine was prepared according to a previous method[@bib6] by hydrolyzing hazimycin A under acidic conditions. Hazimycin A (20.0 mg) was dissolved in 12 mol/L HCl (1.0 mL), and then hydrolyzed at 60°C for 12 h. The reaction solution was neutralized with 10 mol/L NaOH, and then centrifuged to precipitate the resulting salts. Finally, the collected supernatant was purified using HPLC (column: Develosil C30, 250 mm×20 mm; solvent: 3.0% CH~3~CN; detection: UV at 210 nm; flow: 6.0 mL/min). The peak eluted at 16.7 min was repeatedly collected and concentrated to dryness to give dityrosine (10.2 mg) as a white powder. The spectroscopic data listed below were consistent with the findings of a previous study[@bib6].

Dityrosine: FAB-MS-positive; \[M+H\]^+^=361, ^1^H NMR in DMSO-*d*~*6*~ (600 MHz) *δ*~H~; 2.90 (2H), 3.03 (2H), 3.93 (2H), 6.80 (2H), 7.01 (2H), 7.16 (1H), 7.19 (1H), ^13^C NMR in DMSO-*d*~*6*~ (150 MHz) *δ*~C~; 34.8, 35.4, 54.0, 54.5, 115.8, 116.0, 125.6, 126.0, 126.3, 129.5, 130.1, 133.2, 133.4, 153.2, 153.3, 170.6, 170.8, \[*α*\]~D~^28^; --3.54 (*c*=0.1, 1 mol/L HCl).

3.4. Assay for antimicrobial activity {#s0045}
-------------------------------------

Antimicrobial activity against 7 test microorganisms as listed in [Table 3](#t0015){ref-type="table"} was measured using paper disks (6 mm, ADVANTEC) containing a sample, according to our established method[@bib8].
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###### 

^1^H and ^13^C NMR chemical shifts of **1**--**3**.

Table 2

  Position   **1**    **2**                                       Position   **3**                                                            
  ---------- -------- ------------------------------------------- ---------- ----------------------------------- ------------------- -------- -----------------------------
  1          167.1s   --                                          119.0s     --                                  1, 1″               119.0s   --
  1-NH~2~    --       7.48 (1H, s), 7.71 (1H, s)                  --         --                                  1-NH~2~, 1″-NH~2~   --       --
  2          58.9d    4.49 (1H, dd, *J*=4.8, 4.4)                 40.1d      4.98 (1H, dd, *J*=8.0, 7.6)         2, 2″               40.4d    4.90 (1H, dd, *J*=8.0, 7.6)
  2-NH       --       --                                          --         8.86 (1H, d, *J*=7.6)               2-NH, 2″-NH         --       8.86 (1H, d, *J*=7.6)
  3          37.8t    2.86 (1H, m), 3.03 (1H, dd, *J*=8.8, 4.8)   36.5t      2.98 (1H, m)                        3, 3″               36.5t    2.98 (1H, m)
  4          158.0s   --                                          161.1d     8.06 (1H, s)                        4, 4″               161.1s   8.06 (1H, s)
  1′         126.0s   --                                          125.3s     --                                  1′. 1‴              125.2s   --
  2′         132.2d   7.07 (1H, s)                                132.5d     7.07 (1H, s)                        2′, 2‴              132.5d   7.08 (1H, s)
  3′         125.4s   --                                          126.0s     --                                  3′, 3‴              125.7s   --
  4′         153.7s   --                                          153.7s     --                                  4′, 4‴              153.9s   --
  5′         115.7d   6.80 (1H, d, *J*=8.0)                       115.8d     6.81 (1H, d, *J*=8.8)               5′, 5‴              115.8d   6.80 (1H, d, *J*=8.4)
  6′         128.9d   7.03 (1H, d, *J*=8.0)                       128.9d     7.05 (1H, d, *J*=8.8)               6′, 6‴              129.0d   7.05 (1H, d, *J*=8.4)
  1″         172.8s   --                                          172.8s     --                                                               
  1″-NH~2~   --       7.02 (1H, s), 7.48 (1H, s)                  --         7.04 (1H, s), 7.48 (1H, s)                                       
  2″         52.7d    4.43 (1H, ddd, *J*=8.4, 4.8, 4.0)           52.7d      4.44 (1H, ddd, *J*=8.4, 4.8, 4.0)                                
  2″-NH      --       8.17 (1H, d, *J*=8.4)                       --         8.16 (1H, d, *J*=8.4)                                            
  3″         37.0t    2.65 (1H, m), 2.90 (1H, m)                  36.7t      2.60 (1H, m), 2.91 (1H, m)                                       
  4″         160.9d   7.92 (1H, s)                                160.8d     7.92 (1H, s)                                                     
  1‴         127.8s   --                                          127.8s     --                                                               
  2‴         132.2d   7.02 (1H, s)                                132.2d     7.02 (1H, s)                                                     
  3‴         126.0s   --                                          125.3s     --                                                               
  4‴         153.1s   --                                          153.0s     --                                                               
  5‴         115.5d   6.74 (1H, d, *J*=8.0)                       115.4d     6.75 (1H, d, *J*=8.0)                                            
  6‴         128.8d   6.98 (1H, d, *J*=8.0)                       128.8d     6.98 (1H, d, *J*=8.0)                                            

###### 

Physicochemical properties of **1**--**3**.

Table 1

  Parameter                        **1**                  **2**                  **3**
  -------------------------------- ---------------------- ---------------------- ----------------------
  Appearance                       Pale yellow powder     Colorless oil          Colorless oil
  Molecular formula                C~20~H~20~N~4~O~5~     C~20~H~20~N~4~O~5~     C~20~H~18~N~4~O~4~
  Molecular weight                 396                    396                    378
  HR-ESI-MS (*m*/*z*)                                                            
   Found                           419.1339 \[M+Na\]^+^   419.1338 \[M+Na\]^+^   401.1227 \[M+Na\]^+^
   Calcd.                          419.1331               419.1331               401.1226
  UV (MeOH) *λ*~max~ (nm)/*ε*      212/30,254             212/38,945             214/36,931
                                   289/4514               289/4672               289/5065
  \[*α*\]~D~^28^ (*c*=0.1, MeOH)   −1.4°                  −1.6°                  −10.6°
  IR (KBr) *v*~max~ (cm^−1^)       3400, 3205             3315, 3027             3379, 3021
                                   3086, 2150             2252, 1674             2248, 1673
                                   1671, 1621             1614, 1504             1612, 1500

###### 

Antimicrobial activities of **1**--**4**[a](#tbl3fna){ref-type="table-fn"}.

Table 3

  Test organism                Inhibition zone (diameter, mm)                        
  ---------------------------- -------------------------------------- ---- ---- ---- ----
  Gram-positive bacteria                                                             
   *Mycobacterium smegmatis*   --[b](#tbl3fnb){ref-type="table-fn"}   --   --   19   --
   *Bacillus subtilis*         --                                     --   --   14   --
   *Staphylococcus aureus*     --                                     --   --   23   --
   *Micrococcus luteus*        --                                     --   --   26   --
  Gram-negative bacteria                                                             
   *Escherichia coli*          --                                     --   --   --   --
   *Pseudomonas aeruginosa*    --                                     --   --   --   --
  Yeast                                                                              
   *Candida albicans*          --                                     --   --   20   --

10 μg/6 mm disk.

Can not detect antimicrobial activity.
